Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыДефектологияКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Monita со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

FACTOR XIII AND ITS VAL34LEU POLYMORPHISM IN ATHEROTHROMBOTIC DISEASES   Amir-Houshang Shemirani

FACTOR XIII AND ITS VAL34LEU POLYMORPHISM IN ATHEROTHROMBOTIC DISEASES

60 страниц. 2011 год.
LAP Lambert Academic Publishing
A new method based on real time PCR with FRET and melting curve analysis was developed for the detection of factor XIII A subunit (FXIII-A) Val34Leu polymorphism (V34L). The rapid, simple method is well applicable for large-scale analysis. In whole plasma the onset of FXIII activation is determined by fibrin formation, while the rate of activation is modulated by V34L. FXIII levels were elevated in patients with peripheral artery disease (PAD) and the elevation was more evident in females. The severity of PAD did not show significant correlation with FXIII levels. FXIII levels in the upper tertile conferred a 2-2.3-fold increased risk of PAD to females, i.e., elevated FXIII could be considered a gender specific risk factor of PAD. FXIII-A V34L did not influence the risk of PAD. No association was revealed between the risk of non-fatal atherothrombotic ischemic stroke (AIS) and FXIII-A Val34Leu genotype. In contrast, in females homozygous presentation of Leu34 allele represented a more...
 
- Генерация страницы: 0.04 секунд -